FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023108540> ?p ?o ?g. }

• W2023108540 endingPage "326" @default.
• W2023108540 startingPage "323" @default.
• W2023108540 abstract "Cyclosporin A is implicated in the pathogenesis of post-transplantation bone disease. Because of recent evidence that cyclosporin A may cause renal and cardiovascular toxicity by inhibiting nitric oxide (NO) activity, and that NO slows bone remodeling and bone loss in animal and human studies, we investigated a possible link between NO production and beneficial effects on bone health in cyclosporin A-treated rats. Thirty-six 10-week-old male rats were assigned to six groups of six animals each, and treated for 4 weeks with: vehicle; cyclosporin A; l-arginine; NG-nitro-l-arginine methylester (l-NAME, a general inhibitor of NO synthase activity); a combination of cyclosporin A+l-arginine; and a combination of cyclosporin A+l-NAME. Whole body and regional (spine and pelvis) bone mineral content of rats were measured under basal conditions and at the end of the treatment period by dual-energy X-ray absorptiometry (DXA) scanning. Femur weights and serum concentrations of pyridinoline, a reliable marker of bone resorption, were measured at the end of the study period. Cyclosporin A-, l-NAME-, and cyclosporin A+l-NAME-treated rats had significantly lower bone mineral content and femur weights, and significantly higher pyridinoline levels than did control animals. The administration of l-arginine appeared to prevent bone loss caused by cyclosporin A, suggesting that this amino acid, which can be converted to produce NO, might prove useful in preventing disturbed bone modeling and inhibition of bone growth associated with cyclosporin A therapy." @default.
• W2023108540 created "2016-06-24" @default.
• W2023108540 creator A5000196692 @default.
• W2023108540 creator A5025777582 @default.
• W2023108540 creator A5033081592 @default.
• W2023108540 creator A5057854179 @default.
• W2023108540 creator A5075069096 @default.
• W2023108540 creator A5077056891 @default.
• W2023108540 date "2000-11-01" @default.
• W2023108540 modified "2023-09-28" @default.
• W2023108540 title "l-arginine prevents bone loss and bone collagen breakdown in cyclosporin A-treated rats." @default.
• W2023108540 cites W1972911599 @default.
• W2023108540 cites W1980510970 @default.
• W2023108540 cites W1986690707 @default.
• W2023108540 cites W2011935821 @default.
• W2023108540 cites W2040856583 @default.
• W2023108540 cites W2043545235 @default.
• W2023108540 cites W2051391628 @default.
• W2023108540 cites W2064796150 @default.
• W2023108540 cites W2067150234 @default.
• W2023108540 cites W2070705766 @default.
• W2023108540 cites W2070815389 @default.
• W2023108540 cites W2071563059 @default.
• W2023108540 cites W2162253577 @default.
• W2023108540 doi "https://doi.org/10.1016/s0014-2999(00)00800-1" @default.
• W2023108540 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11090650" @default.
• W2023108540 hasPublicationYear "2000" @default.
• W2023108540 type Work @default.
• W2023108540 sameAs 2023108540 @default.
• W2023108540 citedByCount "40" @default.
• W2023108540 countsByYear W20231085402012 @default.
• W2023108540 countsByYear W20231085402013 @default.
• W2023108540 countsByYear W20231085402014 @default.
• W2023108540 countsByYear W20231085402015 @default.
• W2023108540 countsByYear W20231085402016 @default.
• W2023108540 countsByYear W20231085402017 @default.
• W2023108540 countsByYear W20231085402018 @default.
• W2023108540 countsByYear W20231085402019 @default.
• W2023108540 countsByYear W20231085402020 @default.
• W2023108540 countsByYear W20231085402021 @default.
• W2023108540 countsByYear W20231085402022 @default.
• W2023108540 crossrefType "journal-article" @default.
• W2023108540 hasAuthorship W2023108540A5000196692 @default.
• W2023108540 hasAuthorship W2023108540A5025777582 @default.
• W2023108540 hasAuthorship W2023108540A5033081592 @default.
• W2023108540 hasAuthorship W2023108540A5057854179 @default.
• W2023108540 hasAuthorship W2023108540A5075069096 @default.
• W2023108540 hasAuthorship W2023108540A5077056891 @default.
• W2023108540 hasConcept C126322002 @default.
• W2023108540 hasConcept C131075544 @default.
• W2023108540 hasConcept C134018914 @default.
• W2023108540 hasConcept C141071460 @default.
• W2023108540 hasConcept C160160445 @default.
• W2023108540 hasConcept C170033053 @default.
• W2023108540 hasConcept C181199279 @default.
• W2023108540 hasConcept C185592680 @default.
• W2023108540 hasConcept C2776541429 @default.
• W2023108540 hasConcept C2776886416 @default.
• W2023108540 hasConcept C2777083390 @default.
• W2023108540 hasConcept C2777468819 @default.
• W2023108540 hasConcept C2778588143 @default.
• W2023108540 hasConcept C2780554211 @default.
• W2023108540 hasConcept C515207424 @default.
• W2023108540 hasConcept C519581460 @default.
• W2023108540 hasConcept C55493867 @default.
• W2023108540 hasConcept C673006 @default.
• W2023108540 hasConcept C71924100 @default.
• W2023108540 hasConceptScore W2023108540C126322002 @default.
• W2023108540 hasConceptScore W2023108540C131075544 @default.
• W2023108540 hasConceptScore W2023108540C134018914 @default.
• W2023108540 hasConceptScore W2023108540C141071460 @default.
• W2023108540 hasConceptScore W2023108540C160160445 @default.
• W2023108540 hasConceptScore W2023108540C170033053 @default.
• W2023108540 hasConceptScore W2023108540C181199279 @default.
• W2023108540 hasConceptScore W2023108540C185592680 @default.
• W2023108540 hasConceptScore W2023108540C2776541429 @default.
• W2023108540 hasConceptScore W2023108540C2776886416 @default.
• W2023108540 hasConceptScore W2023108540C2777083390 @default.
• W2023108540 hasConceptScore W2023108540C2777468819 @default.
• W2023108540 hasConceptScore W2023108540C2778588143 @default.
• W2023108540 hasConceptScore W2023108540C2780554211 @default.
• W2023108540 hasConceptScore W2023108540C515207424 @default.
• W2023108540 hasConceptScore W2023108540C519581460 @default.
• W2023108540 hasConceptScore W2023108540C55493867 @default.
• W2023108540 hasConceptScore W2023108540C673006 @default.
• W2023108540 hasConceptScore W2023108540C71924100 @default.
• W2023108540 hasIssue "3" @default.
• W2023108540 hasLocation W20231085401 @default.
• W2023108540 hasLocation W20231085402 @default.
• W2023108540 hasOpenAccess W2023108540 @default.
• W2023108540 hasPrimaryLocation W20231085401 @default.
• W2023108540 hasRelatedWork W1967422973 @default.
• W2023108540 hasRelatedWork W2037111705 @default.
• W2023108540 hasRelatedWork W2053638911 @default.
• W2023108540 hasRelatedWork W2105853087 @default.
• W2023108540 hasRelatedWork W2128714854 @default.
• W2023108540 hasRelatedWork W2414556147 @default.
• W2023108540 hasRelatedWork W282095497 @default.

• next